Learn how to integrate non-invasive autonomic and vascular testing into your practice to enhance risk stratification and transition toward proactive cardiac care.
Published November 2, 2026 · Updated November 5, 2026
Traditional cardiovascular care has long focused on reactive management—treating symptomatic coronary artery disease, heart failure, and arrhythmias after they manifest. However, the paradigm is shifting toward preventive cardiology, where early detection of subclinical autonomic and vascular dysfunction allows for intervention before major adverse cardiac events occur. By integrating comprehensive diagnostic tools into your practice, you can transition your clinic from a reactive model to a proactive, evidence-based wellness engine.
The autonomic nervous system (ANS) is the primary integrator of cardiovascular homeostasis. Dysautonomia, often manifesting as reduced HRV risk stratification scores, is frequently an early warning sign of impending cardiovascular decline, even in patients who appear asymptomatic during routine physicals.
Incorporating autonomic testing cardiology into your workflow provides objective, quantifiable data on the sympathetic and parasympathetic balance. The VitalScan ANS+ system, developed by US MedResources, offers a non-invasive diagnostic suite that bridges the gap between traditional ECG and advanced cardiac imaging. By assessing metrics such as Heart Rate Variability (HRV) and the Valsalva ratio, clinicians can identify high-risk patients who might otherwise be missed by standard lipid panels or blood pressure checks.
A robust cardiovascular screening program must evaluate both neural and mechanical vascular health. The VitalScan ANS+ system streamlines this by capturing critical vascular data in a single visit:
By leveraging these tools, a vascular screening program becomes an extension of your primary care workflow, allowing you to identify patients with occult vascular disease early in their clinical journey.
One of the most significant barriers to building a preventive program is operational overhead. The VitalScan ANS+ system is specifically engineered for high-throughput cardiology clinics. Because the diagnostic process takes only 15 minutes and can be administered by clinical staff—with no specialized technician required—it integrates seamlessly into the standard patient visit. The automated interpretive report, available before the patient departs, facilitates immediate patient counseling and shared decision-making.
From a practice management perspective, incorporating these diagnostics is financially viable. The testing protocols map directly to existing CPT codes:
These codes allow practices to maintain sustainable revenue cycles while providing medically necessary, guideline-directed diagnostic oversight for patients with diabetes, hypertension, or suspected autonomic instability.
Integrating these diagnostics aligns with the broader goals of the AHA and ACC, which emphasize the importance of identifying subclinical markers of atherosclerosis and autonomic impairment. By utilizing objective metrics like PWV and HRV, your clinic is not only providing superior care but is also adhering to the standard of care recommended for high-risk cohorts, including patients with metabolic syndrome or type 2 diabetes, where the American Diabetes Association (ADA) strongly recommends screening for autonomic complications.
Transitioning to a proactive cardiology model requires diagnostic precision that is both rapid and accessible. The VitalScan ANS+ system enables your practice to deliver objective HRV risk stratification and vascular assessment in just 15 minutes. By integrating these non-invasive diagnostics, you can identify subclinical disease earlier, optimize preventative pharmacological or lifestyle interventions, and significantly improve long-term cardiovascular health outcomes for your patient population.
One-Page Reference
Code descriptions, typical reimbursement ranges, ICD-10 pairings, and the CMS bundling note to check before you bill.
Combine cardiac autonomic testing with your vascular studies at your own volume and reimbursement, and see the annual figure.